The Long-Term Effectiveness and Safety of Omalizumab on Patient- and Physician-Reported Asthma Control: A Three-Year, Real-Life Observational Study

被引：0
|
作者：
Jens Schreiber
Inessa Schwab Sauerbeck
Claudia Mailänder
机构：
[1] Novartis Pharma GmbH,Department of Pulmonology
[2] Clinical Research Respiratory,undefined
[3] University Hospital,undefined
[4] Otto-von-Guericke-University Magdeburg,undefined
来源：
Advances in Therapy | 2020年 / 37卷
关键词：
Asthma control questionnaire; Global evaluation of treatment effectiveness; Omalizumab; Safety; Severe allergic asthma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：353 / 363
页数：10
相关论文
共 50 条
  • [1] The Long-Term Effectiveness and Safety of Omalizumab on Patient- and Physician-Reported Asthma Control: A Three-Year, Real-Life Observational Study
    Schreiber, Jens
    Sauerbeck, Inessa Schwab
    Mailaender, Claudia
    ADVANCES IN THERAPY, 2020, 37 (01) : 353 - 363
  • [2] Unlocking the Long-Term Effectiveness of Benralizumab in Severe Eosinophilic Asthma: A Three-Year Real-Life Study
    Pini, Laura
    Bagnasco, Diego
    Beghe, Bianca
    Braido, Fulvio
    Cameli, Paolo
    Caminati, Marco
    Caruso, Cristiano
    Crimi, Claudia
    Guarnieri, Gabriella
    Latorre, Manuela
    Menzella, Francesco
    Micheletto, Claudio
    Vianello, Andrea
    Visca, Dina
    Bondi, Benedetta
    El Masri, Yehia
    Giordani, Jordan
    Mastrototaro, Andrea
    Maule, Matteo
    Pini, Alessandro
    Piras, Stefano
    Zappa, Martina
    Senna, Gianenrico
    Spanevello, Antonio
    Paggiaro, Pierluigi
    Blasi, Francesco
    Canonica, Giorgio Walter
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (10)
  • [3] Long-term efficacy and safety of omalizumab in patients with allergic asthma: A real-life study
    Papaioannou, Andriana, I
    Mplizou, Myrto
    Porpodis, Konstantinos
    Fouka, Evangelia
    Zervas, Eleftherios
    Samitas, Konstantinos
    Markatos, Miltiadis
    Bakakos, Petros
    Papiris, Spyridon
    Gaga, Mina
    Papakosta, Despoina
    Loukides, Stelios
    ALLERGY AND ASTHMA PROCEEDINGS, 2021, 42 (03) : 235 - 242
  • [4] Long-term "real-life" safety of omalizumab in patients with severe uncontrolled asthma: A nine-year study
    Di Bona, Danilo
    Fiorino, Irene
    Taurino, Marialuisa
    Frisenda, Flavia
    Minenna, Elena
    Pasculli, Carlo
    Kourtis, Georgios
    Rucco, Anna Simona
    Nico, Andrea
    Albanesi, Marcello
    Giliberti, Lucia
    D'Elia, Luciana
    Caiaffa, Maria Filomena
    Macchia, Luigi
    RESPIRATORY MEDICINE, 2017, 130 : 55 - 60
  • [5] Long-term effectiveness and safety of dupilumab in severe asthma: a 5-year real-life multicenter observational cohort study
    Dupin, Clairelyne
    Chauvin, Astrid
    Guilleminault, Laurent
    Boudjemaa, Amel
    Ghourabi, Nouha
    Gamez, Anne-Sophie
    Berger, Patrick
    Khayat, Naji
    Bonniaud, Philippe
    Leroyer, Christophe
    Mahay, Guillaume
    Fry, Stephanie
    Girodet, Pierre-Olivier
    Le Bourdelles, Genevieve
    Proust, Alain
    Rosencher, Lise
    Garcia, Gilles
    Bourdin, Arnaud
    Belhadi, Drifa
    Didier, Alain
    Couffignal, Camille
    Taille, Camille
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [6] Retrospective Observational Study to Evaluate Long-Term Effectiveness and Safety of Omalizumab Treatment in Real-Life Setting in Allergy Centre of Spain
    Marquez Hernandez, Dorkas Margarita
    Bastidas, Jose A.
    Herraez, Lys
    Mederos, Elena
    Enriquez Matas, A.
    Mielgo Ballesteros, Ruth
    Fernandez, Consuelo
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB12 - AB12
  • [7] Real-life long-term omalizumab therapy in children with severe allergic asthma
    Deschildre, Antoine
    Marguet, Christophe
    Langlois, Carole
    Pin, Isabelle
    Rittie, Jean-Luc
    Derelle, Jocelyne
    Abou Taam, Rola
    Fayon, Michael
    Brouard, Jacques
    Dubus, Jean Christophe
    Siret, Daniel
    Weiss, Laurence
    Pouessel, Guillaume
    Beghin, Laurent
    Just, Jocelyne
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46 (03) : 856 - 859
  • [8] Severe asthma and long-term Benralizumab effectiveness in real-life
    Sposato, B.
    Scalese, M.
    Camiciottoli, G.
    Carpagnano, G. E.
    Pelaia, C.
    Santus, P.
    Pelaia, G.
    Palmiero, G.
    Di Tomassi, M.
    Ronchi, M. C.
    Cameli, P.
    Bargagli, E.
    Ciambellotti, L.
    Rizzello, S.
    Sglavo, R.
    Coppola, A.
    Lacerenza, L. G.
    Gabriele, M.
    Radovanovic, D.
    Perrella, A.
    Ricci, A.
    Rogliani, P.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (20) : 7461 - 7473
  • [9] A Comparison between Patient- and Physician-Reported Late Radiation Toxicity in Long-Term Prostate Cancer Survivors
    Nuijens, Anna C.
    Oei, Arlene L.
    Bouhuijs, Anne
    Franken, Nicolaas A. P.
    Rasch, Coen R. N.
    Stalpers, Lukas J. A.
    CANCERS, 2022, 14 (07)
  • [10] Real-life long-term safety and effectiveness of omalizumab in Japanese pediatric patients with severe allergic asthma: A post-marketing surveillance
    Nakamura, Noriko
    Kashitani, Yuka
    Yoshisue, Hajime
    Nagasaki, Makoto
    Sasajima, Takayoshi
    ALLERGOLOGY INTERNATIONAL, 2021, 70 (03) : 319 - 326
12345